{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:31:51Z","timestamp":1789173111359,"version":"build-2803163510"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cyto.2025.157098","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T19:20:26Z","timestamp":1766517626000},"page":"157098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Advances in lipid nanoparticle delivery systems for targeted cytokine immunotherapy in autoimmune disorders"],"prefix":"10.1016","volume":"198","author":[{"given":"Dilpreet","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.cyto.2025.157098_bb0005","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/intimm\/12.8.1145","article-title":"Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation","volume":"12","author":"Kuniyasu","year":"2000","journal-title":"Int. Immunol."},{"issue":"1299","key":"10.1016\/j.cyto.2025.157098_bb0010","first-page":"51","article-title":"Subsets of CD4+ T cells and their roles in autoimmunity","volume":"342","author":"Mason","year":"1993","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"issue":"4","key":"10.1016\/j.cyto.2025.157098_bb0015","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1051\/jbio\/2002196040263","article-title":"CD4+, CD25+ regulatory T-lymphocytes: current concepts and therapeutic potential","volume":"196","author":"Salomon","year":"2002","journal-title":"J. Soc. Biol."},{"issue":"10","key":"10.1016\/j.cyto.2025.157098_bb0020","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.4049\/jimmunol.179.10.6514","article-title":"CD4+CD28null T cells in autoimmune disease: pathogenic features and decreased susceptibility to immunoregulation","volume":"179","author":"Thewissen","year":"2007","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2025.157098_bb0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0167-5699(95)80068-9","article-title":"Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases","volume":"16","author":"Liblau","year":"1995","journal-title":"Immunol. Today"},{"key":"10.1016\/j.cyto.2025.157098_bb0030","first-page":"5","article-title":"CD4+ T cell metabolism, gut microbiota, and autoimmune diseases: implication in precision medicine of autoimmune diseases. Precis","author":"Yang","year":"2022","journal-title":"Clin. Med."},{"issue":"11","key":"10.1016\/j.cyto.2025.157098_bb0035","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1286-4579(01)01453-8","article-title":"Control of organ-specific autoimmunity by immunoregulatory CD4(+)CD25(+) T cells","volume":"3","author":"McHugh","year":"2001","journal-title":"Microbes Infect."},{"key":"10.1016\/j.cyto.2025.157098_bb0040","first-page":"9","article-title":"Memory CD4+ T cells in immunity and autoimmune diseases","author":"Raphael","year":"2020","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.cyto.2025.157098_bb0045","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4+ CD25+ FOXP3+ regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nature Rev. Immun."},{"key":"10.1016\/j.cyto.2025.157098_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/j.0105-2896.2009.00848.x","article-title":"CD4+CD25+ regulatory T cells in autoimmune arthritis","volume":"233","author":"Oh","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2025.157098_bb0055","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1039\/D1BM01454D","article-title":"Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA)","volume":"10","author":"\u00c1lvarez-Benedicto","year":"2021","journal-title":"Biomater. Sci."},{"issue":"3","key":"10.1016\/j.cyto.2025.157098_bb0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/zeb.2017.1511","article-title":"Lipid nanoparticle packaging is an effective and nontoxic mRNA delivery platform in embryonic zebrafish","volume":"15","author":"Patton","year":"2018","journal-title":"Zebrafish"},{"key":"10.1016\/j.cyto.2025.157098_bb0065","first-page":"1","article-title":"Advancements in lipid nanoparticle technologies for precision targeting in therapeutic delivery","volume":"1","author":"Gao","year":"2024","journal-title":"Precis Nanomed"},{"key":"10.1016\/j.cyto.2025.157098_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202451008","article-title":"Lipid nanoparticle-mediated RNA delivery for immune cell modulation","author":"Kim","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2025.157098_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20230147","article-title":"A perspective of lipid nanoparticles for RNA delivery","volume":"4","author":"Ma","year":"2024","journal-title":"Exploration"},{"key":"10.1016\/j.cyto.2025.157098_bb0080","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles-from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.cyto.2025.157098_bb0085","article-title":"Lipid nanoparticle composition drives mRNA delivery to the placenta","volume":"22","author":"Young","year":"2022","journal-title":"bioRxiv"},{"issue":"8","key":"10.1016\/j.cyto.2025.157098_bb0090","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1021\/jacs.2c12893","article-title":"Ionizable lipid nanoparticles for in vivo mRNA delivery to the placenta during pregnancy","volume":"145","author":"Swingle","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.cyto.2025.157098_bb0095","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1021\/acs.molpharmaceut.2c00442","article-title":"Lipid nanoparticle (LNP) chemistry can endow unique in vivo RNA delivery fates within the liver that alter therapeutic outcomes in a cancer model","volume":"19","author":"Johnson","year":"2022","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.cyto.2025.157098_bb0100","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1039\/D1NR06858J","article-title":"Development of a high-throughput platform for screening lipid nanoparticles for mRNA delivery","volume":"14","author":"Cui","year":"2022","journal-title":"Nanoscale"},{"issue":"3","key":"10.1016\/j.cyto.2025.157098_bb0105","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.33218\/001c.121633","article-title":"Advancements in lipid nanoparticle Technologies for Precision Targeting in therapeutic delivery","volume":"7","author":"Gao","year":"2024","journal-title":"Precis Nanomed."},{"key":"10.1016\/j.cyto.2025.157098_bb0110","article-title":"Spike mRNA vaccine encapsulated in a lipid nanoparticle composed of phospholipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine induced potent B- and T-cell responses associated with protection against COVID-19 in hamsters","author":"Quadiri","year":"2024","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.cyto.2025.157098_bb0115","first-page":"945","article-title":"Recent advances in the lipid nanoparticle-mediated delivery of mRNA vaccines","volume":"11","author":"Swetha","year":"2023","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.cyto.2025.157098_bb0120","first-page":"123","article-title":"Lipid-based nanoparticles (LNP) structures used for drug delivery and targeting: clinical trials and patents","volume":"13","author":"Salome","year":"2023","journal-title":"Nanoscience & Nanotechnology-Asia."},{"key":"10.1016\/j.cyto.2025.157098_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.cocis.2021.101468","article-title":"Opportunities for innovation: building on the success of lipid nanoparticle vaccines","volume":"55","author":"Huang","year":"2021","journal-title":"Curr. Opin. Colloid Interface Sci."},{"issue":"1","key":"10.1016\/j.cyto.2025.157098_bb0130","first-page":"45","article-title":"Latest delivery advancements of lipid nanoparticles for Cancer treatment","volume":"22","author":"Chauhan","year":"2024","journal-title":"Assay Drug Dev. Technol."},{"issue":"29B","key":"10.1016\/j.cyto.2025.157098_bb0135","first-page":"31","article-title":"Herbal liposomes: natural network for targeted drug delivery system","volume":"33","author":"Salunkhe","year":"2021","journal-title":"J. Pharm. Res."},{"key":"10.1016\/j.cyto.2025.157098_bb0140","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.37819\/nanofab.8.1773","article-title":"Lipid and polymer based nano-phytotherapeutics","volume":"8","author":"Bagade","year":"2023","journal-title":"Nanofabrication"},{"key":"10.1016\/j.cyto.2025.157098_bb0145","first-page":"1","article-title":"Novel drug delivery systems for delivery of herbal medicine","author":"Jadhav","year":"2023","journal-title":"Int J Adv Res Sci Commun Technol."},{"key":"10.1016\/j.cyto.2025.157098_bb0150","first-page":"1","article-title":"Drug delivery through targeted approach with special references to phytosomes","author":"Rana","year":"2020","journal-title":"Role Novel Drug Deliv Vehicles Nanobiomedicine."},{"issue":"12","key":"10.1016\/j.cyto.2025.157098_bb0155","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.3390\/pharmaceutics14122681","article-title":"Anticancer applications of essential oils formulated into lipid-based delivery nanosystems","volume":"14","author":"Jamp\u00edlek","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cyto.2025.157098_bb0160","first-page":"1","article-title":"Lipid nanocarriers encapsulating herbal drugs for brain diseases therapy","author":"Gad","year":"2023","journal-title":"Arch Pharm Sci Ain Shams Univ."},{"key":"10.1016\/j.cyto.2025.157098_bb0165","article-title":"Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics","volume":"42","author":"Mukai","year":"2022","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.cyto.2025.157098_bb0170","first-page":"1234567","article-title":"Advancements in programmable lipid nanoparticles: exploring the four-domain model for targeted drug delivery","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.cyto.2025.157098_bb0175","first-page":"15","article-title":"Lipid nanoparticles as platforms for Theranostic purposes: recent advances in the field","volume":"3","author":"Naziri","year":"2022","journal-title":"J. Nanotheranostics."},{"issue":"4","key":"10.1016\/j.cyto.2025.157098_bb0180","first-page":"567","article-title":"Engineering carrier nanoparticles with biomimetic moieties for improved intracellular targeted delivery of mRNA therapeutics and vaccines","volume":"75","author":"Puccetti","year":"2023","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.cyto.2025.157098_bb0185","first-page":"1","article-title":"Nano-encapsulation and conjugation applied in the development of lipid nanoparticles delivering nucleic acid materials to enable gene therapies","volume":"5","author":"Dinh","year":"2024","journal-title":"Appl. Nanosci."},{"issue":"5","key":"10.1016\/j.cyto.2025.157098_bb0190","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3390\/pharmaceutics16050644","article-title":"Lipid nanoparticles in lung Cancer therapy","volume":"16","author":"Omidian","year":"2024","journal-title":"Pharmaceutics"},{"issue":"34","key":"10.1016\/j.cyto.2025.157098_bb0195","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1039\/C7TB01635B","article-title":"ZPDevising new lipid-coated calcium phosphate\/carbonate hybrid nanoparticles for controlled release in endosomes for efficient gene delivery","volume":"5","author":"Wu","year":"2017","journal-title":"Journal of Materials Chemistry B"},{"issue":"5","key":"10.1016\/j.cyto.2025.157098_bb0200","doi-asserted-by":"crossref","first-page":"255","DOI":"10.52601\/bpr.2023.230022","article-title":"Surface engineering of lipid nanoparticles: targeted nucleic acid delivery and beyond","volume":"9","author":"Lin","year":"2023","journal-title":"Biophys. Rep."},{"issue":"7","key":"10.1016\/j.cyto.2025.157098_bb0205","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2217\/nnm-2023-0052","article-title":"The role of formulation approaches in presenting targeting ligands on lipid nanoparticles","volume":"18","author":"Castro","year":"2023","journal-title":"Nanomedicine (Lond.)"},{"issue":"42","key":"10.1016\/j.cyto.2025.157098_bb0210","doi-asserted-by":"crossref","first-page":"21150","DOI":"10.1073\/pnas.1906182116","article-title":"Lipid nanoparticle-targeted mRNA therapy as a treatment for arginase deficiency","volume":"116","author":"Truong","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.cyto.2025.157098_bb0215","article-title":"Recent advances in lipid nanoparticles and their translational potential for the treatment of solid Tumors","volume":"8","author":"Paun","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.cyto.2025.157098_bb0220","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.37349\/etat.2024.00272","article-title":"Exploring the therapeutic potential of lipid-based nanoparticles in the Management of Oral Squamous Cell Carcinoma","volume":"5","author":"Chaudhary","year":"2024","journal-title":"Explor. Target Anti-tumor Ther."},{"issue":"1","key":"10.1016\/j.cyto.2025.157098_bb0225","first-page":"45","article-title":"Latest delivery advancements of lipid nanoparticles for Cancer treatment","volume":"22","author":"Chauhan","year":"2024","journal-title":"Assay Drug Dev. Technol."},{"issue":"2","key":"10.1016\/j.cyto.2025.157098_bb0230","first-page":"178","article-title":"Production of mRNA lipid nanoparticles using advanced crossflow micromixing","volume":"76","author":"Hussain","year":"2024","journal-title":"J. Pharm. Pharmacol."},{"issue":"5","key":"10.1016\/j.cyto.2025.157098_bb0235","first-page":"341","article-title":"The role of formulation approaches in presenting targeting ligands on lipid nanoparticles","volume":"18","author":"Castro","year":"2023","journal-title":"Nanomedicine"},{"issue":"2","key":"10.1016\/j.cyto.2025.157098_bb0240","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejpb.2010.02.007","article-title":"Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging","volume":"75","author":"Goutayer","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.cyto.2025.157098_bb0245","first-page":"1287","article-title":"Advancements in lipid nanoparticle Technologies for Precision Targeting in therapeutic delivery","volume":"7","author":"Gao","year":"2024","journal-title":"Precis Nanomed."},{"issue":"4","key":"10.1016\/j.cyto.2025.157098_bb0250","first-page":"1352","article-title":"Lipid nanoparticle (LNP) chemistry can endow unique in vivo RNA delivery fates within the liver that Alter therapeutic outcomes in a Cancer model","volume":"19","author":"Johnson","year":"2022","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.cyto.2025.157098_bb0255","article-title":"In vivo delivery processes and development strategies of lipid nanoparticles","volume":"25","author":"Cheng","year":"2024","journal-title":"Chembiochem"},{"issue":"42","key":"10.1016\/j.cyto.2025.157098_bb0260","doi-asserted-by":"crossref","first-page":"22659","DOI":"10.1021\/jacs.3c07811","article-title":"Modular bioorthogonal lipid nanoparticle modification platforms for cardiac homing","volume":"145","author":"Cruz-Samperio","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.cyto.2025.157098_bb0265","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3390\/pharmaceutics15061603","article-title":"Increased bone marrow uptake and accumulation of very-late Antigen-4 targeted lipid nanoparticles","volume":"15","author":"Swart","year":"2023","journal-title":"Pharmaceutics"},{"issue":"30","key":"10.1016\/j.cyto.2025.157098_bb0270","first-page":"14658","article-title":"Iterative Design of Ionizable Lipids for intramuscular mRNA delivery","volume":"145","author":"Tilstra","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.cyto.2025.157098_bb0275","doi-asserted-by":"crossref","first-page":"255","DOI":"10.52601\/bpr.2023.230022","article-title":"Surface engineering of lipid nanoparticles: targeted nucleic acid delivery and beyond","volume":"9","author":"Lin","year":"2023","journal-title":"Biophys. Rep."},{"issue":"21","key":"10.1016\/j.cyto.2025.157098_bb0280","article-title":"Harnessing topology and stereochemistry of Glycidylamine-derived lipid nanoparticles for in vivo mRNA delivery to immune cells in spleen and their application for Cancer vaccination","volume":"33","author":"Elwakil","year":"2023","journal-title":"Adv. Funct. Mater."},{"issue":"8","key":"10.1016\/j.cyto.2025.157098_bb0285","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1089\/104303401750195854","article-title":"Interleukin 2 gene therapy for prostate cancer: phase I clinical trial and basic biology","volume":"12","author":"Belldegrun","year":"2001","journal-title":"Hum. Gene Ther."},{"issue":"13","key":"10.1016\/j.cyto.2025.157098_bb0290","first-page":"3875","article-title":"A phase I study of recombinant interleukin 2 plus recombinant beta-interferon","volume":"48","author":"Krigel","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.cyto.2025.157098_bb0295","article-title":"Targeted LNPs deliver mRNA encoding IL-15 superagonists to balance efficacy and toxicity in cancer therapy","author":"Yu","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.cyto.2025.157098_bb0300","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1039\/D4PM00128A","article-title":"Tailoring lipid nanoparticle dimensions through manufacturing processes","volume":"1","author":"McMillan","year":"2024","journal-title":"RSC Pharmaceutics."},{"key":"10.1016\/j.cyto.2025.157098_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108231","article-title":"The oral vaccine based on self-replicating RNA lipid nanoparticles can simultaneously neutralize both SARS-CoV-2 variants alpha and delta","volume":"101","author":"Mohammadi","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.cyto.2025.157098_bb0310","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jaad.2006.08.067","article-title":"Phase II trial of subcutaneous injections of human recombinant interleukin-2 for the treatment of mycosis fungoides and S\u00e9zary syndrome","volume":"56","author":"Querfeld","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.cyto.2025.157098_bb0315","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00002371-199511000-00006","article-title":"A phase II trial of interleukin-2 and interferon-alpha in the treatment of metastatic colorectal carcinoma","volume":"18","author":"Chang","year":"1995","journal-title":"J. Immunother."},{"issue":"4","key":"10.1016\/j.cyto.2025.157098_bb0320","doi-asserted-by":"crossref","DOI":"10.1063\/5.0041311","article-title":"Construction of PD-L1-siRNA and IL-2 DNA loading PEI lipid nanoparticles in activating T cells and treating lung cancer","volume":"11","author":"Gao","year":"2021","journal-title":"AIP Adv."},{"key":"10.1016\/j.cyto.2025.157098_bb0325","doi-asserted-by":"crossref","first-page":"TPS2696","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS2696","article-title":"A phase I trial of intratumoral STX-001: a novel self-replicating mRNA expressing IL-12 alone or with pembrolizumab in advanced solid tumors","volume":"42","author":"Luke","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cyto.2025.157098_bb0330","first-page":"882","article-title":"Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunity","volume":"1","author":"Li","year":"2020","journal-title":"Nat. Can."},{"key":"10.1016\/j.cyto.2025.157098_bb0335","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.2147\/IJN.S117618","article-title":"Cationic PEGylated liposomes incorporating an antimicrobial peptide tilapia hepcidin 2\u20133: an adjuvant of epirubicin to overcome multidrug resistance in cervical cancer cells","volume":"11","author":"Juang","year":"2016","journal-title":"Int. J. Nanomedicine"},{"issue":"41","key":"10.1016\/j.cyto.2025.157098_bb0340","doi-asserted-by":"crossref","first-page":"26262","DOI":"10.1021\/acsomega.0c04111","article-title":"PEGylation of Polyethylenimine lowers acute toxicity while retaining anti-biofilm and \u03b2-lactam potentiation properties against antibiotic-resistant pathogens","volume":"5","author":"Lam","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.cyto.2025.157098_bb0345","article-title":"PEGylation and formulation strategy of anti-microbial peptide (AMP) according to the quality by design approach","volume":"137","author":"Manteghi","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.cyto.2025.157098_bb0350","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/sci6040066","article-title":"Assessing the antimicrobial efficacy of graphene oxide and its PEGylated derivative against Staphylococcus aureus","volume":"6","author":"Gilsanz-Mu\u00f1oz","year":"2024","journal-title":"Sci"},{"key":"10.1016\/j.cyto.2025.157098_bb0355","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cbi.2015.08.023","article-title":"Co-encapsulation of chrysophsin-1 and epirubicin in PEGylated liposomes circumvents multidrug resistance in HeLa cells","volume":"242","author":"Lo","year":"2015","journal-title":"Chem. Biol. Interact."},{"issue":"10","key":"10.1016\/j.cyto.2025.157098_bb0360","doi-asserted-by":"crossref","first-page":"2400145","DOI":"10.1002\/smsc.202400145","article-title":"Ionizable lipid containing nanocarriers for antimicrobial agent delivery","volume":"4","author":"Yu","year":"2024","journal-title":"Small Sci"},{"key":"10.1016\/j.cyto.2025.157098_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090180","article-title":"Reversing multidrug resistance in Caco-2 by silencing MDR1, MRP1, MRP2, and BCL-2\/BCL-xL using liposomal antisense oligonucleotides","volume":"9","author":"Lo","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.cyto.2025.157098_bb0370","first-page":"1","article-title":"PEGylated lipid bilayer-wrapped nano-graphene oxides for synergistic co-delivery of doxorubicin and rapamycin to prevent drug resistance in cancers","volume":"28","author":"Thapa","year":"2017","journal-title":"Nanotechnology"},{"key":"10.1016\/j.cyto.2025.157098_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2020.114339","article-title":"PEGylation of dendronized silver nanoparticles increases the binding affinity of antimicrobial proteins","volume":"319","author":"Ciepluch","year":"2020","journal-title":"J. Mol. Liq."},{"issue":"9","key":"10.1016\/j.cyto.2025.157098_bb0380","first-page":"5348","article-title":"PEGylation of the antimicrobial peptide PG-1: a link between propensity for Nanostructuring and capacity of the antitrypsin hydrolytic ability","volume":"64","author":"Yu","year":"2021","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.cyto.2025.157098_bb0385","first-page":"215","article-title":"Nanotechnology approaches for Cancer immunotherapy and immunomodulation","volume":"8","author":"Fuente","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.cyto.2025.157098_bb0390","doi-asserted-by":"crossref","first-page":"1421959","DOI":"10.3389\/fmolb.2024.1421959","article-title":"Lipid-based nanoparticles: innovations in ocular drug delivery","volume":"11","author":"Baig","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.cyto.2025.157098_bb0395","article-title":"Pharmacosomes: an emerging novel vesicular drug delivery system for poorly soluble synthetic and herbal drugs","volume":"2013","author":"Pandita","year":"2013","journal-title":"ISRN Pharm."},{"issue":"4","key":"10.1016\/j.cyto.2025.157098_bb0400","first-page":"669","article-title":"Lipid-based delivery systems in development of genetic and subunit vaccines","volume":"65","author":"Bolhassani","year":"2022","journal-title":"Mol. Biotechnol."},{"issue":"6","key":"10.1016\/j.cyto.2025.157098_bb0405","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3390\/molecules27061943","article-title":"Modification of lipid-based nanoparticles: an efficient delivery system for nucleic acid-based immunotherapy","volume":"27","author":"Zhang","year":"2022","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.cyto.2025.157098_bb0410","first-page":"1","article-title":"Influences of nanocarrier morphology on therapeutic immunomodulation","volume":"14","author":"Frey","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.cyto.2025.157098_bb0415","first-page":"295","article-title":"Nanosystems for Oral delivery of immunomodulators","volume":"2017","author":"Kharkar","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"4","key":"10.1016\/j.cyto.2025.157098_bb0420","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.actbio.2013.12.011","article-title":"Immunological principles regulating immunomodulation with biomaterials","volume":"10","author":"Khan","year":"2014","journal-title":"Acta Biomater."},{"issue":"15","key":"10.1016\/j.cyto.2025.157098_bb0425","article-title":"Physical and chemical cues at Nano-bio Interface for immunomodulation","volume":"61","author":"Wang","year":"2022","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"4","key":"10.1016\/j.cyto.2025.157098_bb0430","first-page":"1289","article-title":"The shape of nanostructures encodes immunomodulation of carbohydrate antigen and vaccine development","volume":"17","author":"Toraskar","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.cyto.2025.157098_bb0435","article-title":"Nanomaterials for direct and indirect immunomodulation: a review of applications","volume":"136","author":"Kubackov\u00e1","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.cyto.2025.157098_bb0440","first-page":"1","article-title":"Calligraphy of Nanoplasmonic bioink-based multiplex immunosensor for precision immune monitoring and modulation","volume":"15","author":"He","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"3","key":"10.1016\/j.cyto.2025.157098_bb0445","article-title":"Immunomodulation with nucleic acid nanodevices","volume":"19","author":"Ding","year":"2023","journal-title":"Small"},{"issue":"4","key":"10.1016\/j.cyto.2025.157098_bb0450","article-title":"Advanced immunomodulatory biomaterials for therapeutic applications","volume":"13","author":"Park","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"9","key":"10.1016\/j.cyto.2025.157098_bb0455","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1021\/acsbiomaterials.0c00804","article-title":"Nanomaterials as smart immunomodulator delivery system for enhanced Cancer therapy","volume":"6","author":"Yuan","year":"2020","journal-title":"ACS Biomater Sci. Eng."},{"issue":"4","key":"10.1016\/j.cyto.2025.157098_bb0460","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1506","article-title":"Immunoengineering with biomaterials for enhanced Cancer immunotherapy","volume":"10","author":"Xie","year":"2018","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"7","key":"10.1016\/j.cyto.2025.157098_bb0465","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0973-7847.65322","article-title":"Importance of novel drug delivery systems in herbal medicines","volume":"4","author":"Devi","year":"2010","journal-title":"Pharmacogn. Rev."},{"issue":"3","key":"10.1016\/j.cyto.2025.157098_bb0470","first-page":"223","article-title":"Novel herbal drug delivery system: a review","volume":"1","author":"Sonawane","year":"2023","journal-title":"International Journal of Pharmacy and Herbal Technology."},{"key":"10.1016\/j.cyto.2025.157098_bb0475","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cbi.2019.02.021","article-title":"Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases","volume":"304","author":"Mehta","year":"2019","journal-title":"Chem. Biol. Interact."},{"issue":"9","key":"10.1016\/j.cyto.2025.157098_bb0485","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/mt.2010.105","article-title":"A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes","volume":"18","author":"Sun","year":"2010","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.cyto.2025.157098_bb0490","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1007\/s00210-023-02882-y","article-title":"Advances in nano-based drug delivery systems for the management of cytokine influx-mediated inflammation in lung diseases","volume":"397","author":"Gulati","year":"2024","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625002455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625002455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T16:40:42Z","timestamp":1768063242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466625002455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":97,"alternative-id":["S1043466625002455"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2025.157098","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in lipid nanoparticle delivery systems for targeted cytokine immunotherapy in autoimmune disorders","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2025.157098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157098"}}